Probe sets already associated with B and T leukemias
Probe set IDs . | T1-CT* . | T2-CT* . | T3-CT* . | B1-CT† . | B2-CT† . | B3-CT† . | Gene title . | Gene symbol . |
---|---|---|---|---|---|---|---|---|
Down-regulated B leukemia probe sets | ||||||||
1422122_at | 0.21 | 0.06 | 0.43 | −6.57 | −6.89 | −6.36 | Fc receptor, IgE, low affinity II, α polypeptide | Fcer2a |
1451713_a_at | −0.05 | −0.09 | 0.18 | −6.26 | −5.85 | −5.85 | Fc receptor, IgE, low affinity II, α polypeptide | Fcer2a |
1438030_at | −0.28 | −0.01 | 0.06 | −5.23 | −4.94 | −4.27 | RAS, guanyl releasing protein 3 | Rasgrp3 |
1447998_at | 0.36 | 0.14 | 0.31 | −4.87 | −4.53 | −4.84 | Immunoglobulin heavy chain 4 (serum IgG1) | Igh-4 |
1427292_at | −0.31 | −0.37 | 0.00 | −4.47 | −2.90 | −3.62 | Immunoglobulin λ chain, variable 1 | Igl-V1 |
1439221_s_at | −0.18 | −0.15 | 0.00 | −4.44 | −4.21 | −4.85 | Tumor necrosis factor receptor superfamily, member 5 | Tnfrsf5 |
1443783_x_at | 0.01 | −0.01 | −0.16 | −4.17 | −4.56 | −4.67 | Histocompatibility 2, class II antigen A, α | H2-Aa |
1452521_a_at | −0.01 | −0.54 | −0.20 | −3.98 | −3.90 | −4.23 | Urokinase plasminogen activator receptor | Plaur |
1449473_s_at | −0.53 | −0.40 | −0.27 | −3.85 | −3.90 | −4.69 | Tumor necrosis factor receptor superfamily, member 5 | Tnfrsf5 |
1427306_at | 0.27 | −0.08 | 0.23 | −3.50 | −3.45 | −3.65 | Ryanodine receptor 1, skeletal muscle | Ryr1 |
1438031_at | −0.41 | −0.10 | −0.06 | −3.49 | −3.74 | −3.67 | RAS, guanyl releasing protein 3 | Rasgrp3 |
1442263_at | −0.15 | −0.27 | −0.25 | −3.48 | −3.56 | −3.09 | Regulator of G-protein signaling 13 | Rgs13 |
1419609_at | −0.32 | −0.15 | −0.34 | −3.45 | −3.90 | −3.75 | Chemokine (C-C motif) receptor 1 | Ccr1 |
1416055_at | −0.04 | −0.08 | 0.15 | −3.43 | −3.38 | −3.29 | Amylase 2, pancreatic | Amy2 |
1442544_at | −0.01 | −0.06 | 0.47 | −3.31 | −3.53 | −3.27 | Immunoglobulin heavy chain 4 (serum IgG1) | Igh-4 |
1451965_at | −0.56 | −0.42 | −0.44 | −3.22 | −3.69 | −3.67 | Immunoglobulin κ chain complex | Igk |
1425063_at | −0.07 | −0.29 | −0.02 | −3.15 | −2.98 | −2.85 | Fc receptor-like 1 | Fcrl1 |
1448861_at | 0.50 | −0.13 | 0.51 | −3.15 | −3.18 | −3.30 | Tnf receptor-associated factor 5 | Traf5 |
1425902_a_at | −0.16 | −0.41 | −0.48 | −2.84 | −2.54 | −2.90 | Nuclear factor of κ light polypeptide gene enhancer in B cells 2, p49/p100 | Nfkb2 |
1425289_a_at | −0.10 | 0.15 | 0.58 | −2.82 | −3.56 | −4.96 | Complement receptor 2 | Cr2 |
1420710_at | −0.05 | 0.37 | −0.40 | −2.70 | −2.12 | −2.23 | Reticuloendotheliosis oncogene | Rel |
1427576_at | −0.52 | −0.50 | −0.23 | −2.60 | −3.04 | −3.10 | Immunoglobulin κ chain, constant region | Igk-C |
1450912_at | −0.16 | −0.23 | 0.11 | −2.49 | −2.19 | −3.14 | Membrane-spanning 4-domains, subfamily A, member 1 | Ms4a1 |
1423226_at | −0.03 | 0.32 | 0.48 | −2.32 | −2.03 | −2.79 | Membrane-spanning 4-domains, subfamily A, member 1 | Ms4a1 |
1455019_x_at | −0.30 | −0.48 | 0.10 | −2.43 | −2.68 | −2.52 | Cytoskeleton-associated protein 4 | Ckap4 |
1421211_a_at | −0.38 | −0.14 | −0.41 | −2.37 | −3.83 | −3.85 | Class II transactivator | C2ta |
1420353_at | −0.36 | −0.57 | −0.53 | −2.36 | −3.66 | −3.51 | Lymphotoxin A | Lta |
1422828_at | −0.29 | −0.29 | −0.43 | −2.31 | −2.09 | −2.21 | CD3 antigen, δ polypeptide | Cd3d |
1415899_at | −0.54 | −0.24 | −0.57 | −2.15 | −2.50 | −3.38 | Jun-B oncogene | Junb |
1419714_at | 0.42 | −0.06 | 0.29 | −2.11 | −2.27 | −2.06 | Programmed cell death 1 ligand 1 | Pdcd1lg1 |
1447839_x_at | 0.56 | 0.55 | 0.08 | −2.08 | −2.23 | −2.22 | Adrenomedullin | Adm |
1425802_a_at | −0.26 | 0.23 | −0.06 | −2.07 | −2.25 | −4.45 | Fc receptor-like A | Fcrla |
Up-regulated B leukemia probe sets | ||||||||
1427276_at | 0.20 | 0.39 | 0.50 | 2.03 | 2.63 | 2.12 | SMC4 structural maintenance of chromosomes 4-like 1 (yeast) | Smc4l1 |
1452499_a_at | 0.48 | 0.09 | 0.16 | 2.03 | 2.17 | 2.34 | Kinesin family member 2A | Kif2a |
1436036_at | 0.40 | 0.10 | 0.08 | 2.08 | 2.53 | 2.79 | Wolf-Hirschhorn syndrome candidate 1 (human) | Whsc1 |
1439740_s_at | 0.20 | −0.01 | 0.14 | 2.09 | 2.62 | 2.16 | Uridine-cytidine kinase 2 | Uck2 |
1448531_at | 0.39 | 0.45 | 0.36 | 2.19 | 2.39 | 2.27 | Lamin B2 | Lmnb2 |
1417299_at | −0.24 | −0.31 | 0.23 | 2.38 | 2.94 | 2.50 | NIMA (never in mitosis gene a)-related expressed kinase 2 | Nek2 |
1420909_at | 0.20 | 0.21 | −0.01 | 2.40 | 3.59 | 3.57 | Vascular endothelial growth factor A | Vegfa |
1428853_at | 0.37 | −0.09 | −0.25 | 2.50 | 3.08 | 3.26 | Patched homolog 1 | Ptch1 |
1437716_x_at | −0.18 | −0.27 | −0.08 | 2.54 | 2.94 | 2.43 | Kinesin family member 22 | Kif22 |
1418969_at | 0.11 | −0.11 | −0.05 | 2.57 | 3.04 | 2.53 | S-phase kinase-associated protein 2 (p45) | Skp2 |
1415849_s_at | −0.30 | −0.53 | −0.46 | 2.61 | 3.02 | 2.97 | Stathmin 1 | Stmn1 |
1449293_a_at | −0.01 | −0.43 | −0.22 | 2.72 | 2.87 | 2.65 | S-phase kinase-associated protein 2 (p45) | Skp2 |
1423092_at | −0.27 | −0.57 | 0.49 | 2.74 | 3.13 | 3.10 | Inner centromere protein | Incenp |
1444031_at | 0.50 | 0.17 | 0.02 | 2.76 | 3.05 | 2.34 | Calcium/calmodulin-dependent protein kinase II, δ | Camk2d |
1417656_at | 0.29 | −0.06 | 0.51 | 2.77 | 2.90 | 2.52 | Myeloblastosis oncogene-like 2 | Mybl2 |
1417694_at | −0.20 | −0.39 | −0.19 | 2.81 | 2.83 | 4.08 | Growth factor receptor bound protein 2-associated protein 1 | Gab1 |
1439436_x_at | −0.01 | −0.44 | 0.18 | 2.83 | 3.38 | 3.08 | Inner centromere protein | Incenp |
1424128_x_at | −0.30 | −0.55 | 0.48 | 2.84 | 3.32 | 3.16 | Aurora kinase B | Aurkb |
1446669_at | 0.30 | 0.45 | 0.18 | 2.92 | 2.95 | 2.14 | Early B-cell factor 1 | Ebf1 |
1440244_at | 0.00 | 0.19 | 0.05 | 2.99 | 4.55 | 5.28 | Avian erythroblastosis virus E-26 (v-ets) oncogene related | Erg |
1424278_a_at | −0.54 | −0.46 | −0.47 | 3.09 | 3.58 | 3.10 | Baculoviral IAP repeat-containing 5 | Birc5 |
1460247_a_at | 0.09 | −0.12 | −0.29 | 3.21 | 3.47 | 3.31 | S-phase kinase-associated protein 2 (p45) | Skp2 |
1437580_s_at | −0.44 | −0.56 | −0.10 | 3.23 | 3.47 | 3.29 | NIMA (never in mitosis gene a)-related expressed kinase 2 | Nek2 |
1458447_at | 0.49 | 0.43 | 0.52 | 3.50 | 4.00 | 3.67 | Centromere protein F | Cenpf |
1415810_at | −0.19 | −0.39 | −0.35 | 3.50 | 3.56 | 3.55 | Ubiquitin-like, containing PHD and RING finger domains, 1 | Uhrf1 |
1419943_s_at | −0.50 | −0.52 | −0.03 | 3.50 | 4.23 | 3.84 | Cyclin B1 | Ccnb1 |
1416961_at | −0.11 | −0.12 | 0.34 | 3.56 | 4.14 | 3.69 | Budding uninhibited by benzimidazoles 1 homolog, β (Saccharomyces cerevisiae) | Bub1b |
1424991_s_at | −0.03 | −0.04 | 0.42 | 3.64 | 3.98 | 4.10 | Thymidylate synthase | Tyms |
1417938_at | −0.03 | −0.02 | 0.37 | 3.75 | 4.19 | 3.88 | RAD51-associated protein 1 | Rad51ap1 |
1448899_s_at | −0.38 | −0.31 | 0.24 | 3.76 | 4.13 | 3.84 | RAD51-associated protein 1 | Rad51ap1 |
1416155_at | 0.32 | 0.19 | 0.26 | 3.78 | 4.30 | 4.38 | High mobility group box 3 | Hmgb3 |
1415811_at | 0.37 | −0.03 | −0.11 | 3.91 | 3.95 | 3.94 | Ubiquitin-like, containing PHD and RING finger domains, 1 | Uhrf1 |
1418264_at | −0.04 | −0.39 | 0.35 | 4.16 | 4.52 | 4.55 | SoxLZ/Sox6 leucine zipper binding protein in testis | Solt |
1417910_at | −0.57 | −0.47 | −0.32 | 4.25 | 4.71 | 4.28 | Cyclin A2 | Ccna2 |
1434748_at | −0.27 | −0.36 | −0.21 | 4.30 | 4.78 | 4.21 | Cytoskeleton-associated protein 2 | Ckap2 |
1448205_at | −0.15 | −0.23 | 0.15 | 4.42 | 4.85 | 4.49 | Cyclin B1, related sequence 1 /// cyclin B1 | Ccnb1-rs1///Ccnb1 |
1416076_at | −0.53 | −0.45 | −0.19 | 4.47 | 5.18 | 4.81 | Cyclin B1 | Ccnb1 |
1452315_at | 0.05 | 0.27 | 0.57 | 4.48 | 4.82 | 4.58 | Kinesin family member 11 | Kif11 |
1439820_at | −0.08 | −0.09 | −0.13 | 4.48 | 4.48 | 3.95 | Early B-cell factor 1 | Ebf1 |
1424046_at | −0.04 | −0.02 | −0.03 | 4.56 | 5.27 | 4.79 | Budding uninhibited by benzimidazoles 1 homolog (Saccharomyces cerevisiae) | Bub1 |
1452314_at | −0.14 | −0.18 | 0.10 | 4.58 | 5.06 | 4.63 | Kinesin family member 11 | Kif11 |
1454694_a_at | −0.13 | −0.08 | 0.03 | 4.66 | 5.14 | 4.87 | Topoisomerase (DNA) II α | Top2a |
1418507_s_at | −0.26 | 0.01 | −0.06 | 4.88 | 5.92 | 4.41 | RIKEN cDNA D130043N08 gene | D130043N08Rik |
1447363_s_at | −0.23 | −0.28 | 0.10 | 4.97 | 5.50 | 5.14 | Budding uninhibited by benzimidazoles 1 homolog, β (Saccharomyces cerevisiae) | Bub1b |
1435306_a_at | −0.20 | −0.32 | 0.22 | 5.05 | 5.50 | 5.04 | Kinesin family member 11 | Kif11 |
1424967_x_at | −0.06 | 0.08 | 0.27 | 5.23 | 3.63 | 2.48 | Troponin T2, cardiac | Tnnt2 |
1418726_a_at | 0.29 | 0.11 | 0.20 | 5.49 | 4.30 | 3.17 | Troponin T2, cardiac | Tnnt2 |
1427161_at | 0.31 | 0.43 | 0.28 | 5.67 | 6.30 | 5.92 | Centromere autoantigen F | Cenpf |
1426817_at | 0.25 | 0.39 | 0.41 | 5.64 | 6.09 | 5.88 | Antigen identified by monoclonal antibody Ki 67 | Mki67 |
1420176_x_at | −0.27 | 0.14 | −0.04 | 7.08 | 7.05 | 7.00 | Immunoglobulin λ-like polypeptide 1 | Igll1 |
1448649_at | −0.02 | −0.24 | −0.17 | 9.58 | 9.56 | 9.18 | Glutamyl aminopeptidase | Enpep |
Down-regulated T leukemia probe sets | ||||||||
1427419_x_at | −2.15 | −8.36 | −8.79 | −0.26 | −0.06 | −0.26 | Chemokine (C-C motif) receptor 9 | Ccr9 |
1421919_a_at | −2.68 | −6.65 | −6.65 | 0.03 | −0.06 | −0.30 | Chemokine (C-C motif) receptor 9 | Ccr9 |
1425792_a_at | −2.79 | −3.33 | −5.75 | −0.18 | −0.26 | −0.30 | RAR-related orphan receptor gamma | Rorc |
1423954_at | −3.21 | −2.52 | −3.89 | 0.26 | 0.13 | −0.24 | Complement component 3 | C3 |
1447541_s_at | −2.12 | −2.46 | −2.49 | −0.53 | −0.33 | −0.30 | Integrin, α E, epithelial-associated | Itgae |
1450295_s_at | −2.23 | −2.13 | −2.88 | 0.11 | 0.36 | 0.13 | Poliovirus receptor /// DNA segment, Chr 7, ERATO Doi 458, expressed | Pvr /// D7Ertd458e |
1427411_s_at | −2.60 | −2.07 | −2.24 | −0.33 | −0.31 | 0.06 | Deleted in lymphocytic leukemia, 2 | Dleu2 |
1420413_at | −2.30 | −2.07 | −2.06 | 0.42 | 0.29 | 0.50 | Aolute carrier family 7 (cationic amino acid transporter, y+ system), member 11 | Slc7a11 |
Up-regulated T leukemia probe sets | ||||||||
1449835_at | 2.55 | 2.86 | 5.05 | −0.30 | −0.38 | −0.35 | Programmed cell death 1 | Pdcd1 |
Down-regulated B and T leukemia common probe sets | ||||||||
1427127_x_at | −6.03 | −4.87 | −2.83 | −5.10 | −5.83 | −5.70 | Heat shock protein 1B /// heat shock protein 1A | Hspa1b /// Hspa1a |
1452318_a_at | −5.74 | −4.92 | −3.09 | −4.73 | −5.26 | −5.81 | Heat shock protein 1B | Hspa1b |
1427126_at | −5.23 | −4.56 | −2.76 | −4.92 | −5.53 | −5.75 | Heat shock protein 1B | Hspa1b |
1448123_s_at | −3.86 | −3.54 | −3.37 | −2.85 | −2.70 | −2.36 | Transforming growth factor, β induced | Tgfbi |
1448162_at | −3.84 | −3.92 | −3.30 | −4.15 | −3.86 | −4.01 | Vascular cell adhesion molecule 1 | Vcam1 |
1456250_x_at | −3.57 | −3.18 | −3.79 | −2.29 | −2.18 | −2.24 | Transforming growth factor, β induced | Tgfbi |
1460423_x_at | −3.39 | −2.89 | −2.13 | −6.19 | −6.45 | −7.35 | Ig κ chain | IgM |
1418126_at | −2.89 | −2.92 | −2.91 | −2.02 | −2.34 | −2.80 | Chemokine (C-C motif) ligand 5 | Ccl5 |
1417756_a_at | −2.84 | −5.14 | −3.04 | −2.50 | −3.17 | −2.19 | Lymphocyte specific 1 | Lsp1 |
1449858_at | −2.83 | −2.82 | −2.50 | −4.78 | −4.68 | −2.89 | CD86 antigen | Cd86 |
1449164_at | −2.76 | −3.00 | −3.03 | −2.83 | −2.94 | −2.67 | CD68 antigen | Cd68 |
1418365_at | −2.71 | −3.02 | −2.34 | −4.61 | −4.43 | −5.66 | Cathepsin H | Ctsh |
1415989_at | −2.46 | −2.50 | −2.69 | −2.07 | −2.32 | −2.37 | Vascular cell adhesion molecule 1 | Vcam1 |
1434499_a_at | −2.44 | −2.70 | −6.15 | −2.72 | −2.91 | −2.62 | Lactate dehydrogenase 2, B chain | Ldh2 |
1448237_x_at | −2.43 | −2.82 | −5.89 | −2.01 | −2.07 | −2.07 | Lactate dehydrogenase 2, B chain | Ldh2 |
1450381_a_at | −2.23 | −3.10 | −2.91 | −2.74 | −3.38 | −3.19 | B-cell leukemia/lymphoma 6 | Bcl6 |
1450381_a_at | −2.23 | −3.10 | −2.91 | −2.74 | −3.38 | −3.19 | B-cell leukemia/lymphoma 6 | Bcl6 |
Up-regulated B and T leukemia common probe sets | ||||||||
1422967_a_at | 2.03 | 2.96 | 2.87 | 2.32 | 3.45 | 2.72 | Transferrin receptor | Tfrc |
1422198_a_at | 2.03 | 2.21 | 2.54 | 2.39 | 3.05 | 2.17 | Serine hydroxymethyl transferase 1 (soluble) | Shmt1 |
1425179_at | 2.15 | 2.31 | 2.71 | 2.80 | 3.32 | 2.52 | Serine hydroxymethyl transferase 1 (soluble) | Shmt1 |
1425923_at | 6.04 | 5.92 | 5.57 | 4.66 | 4.87 | 4.19 | v-myc myelocytomatosis viral-related oncogene, neuroblastoma derived (avian) | Mycn |
Probe set IDs . | T1-CT* . | T2-CT* . | T3-CT* . | B1-CT† . | B2-CT† . | B3-CT† . | Gene title . | Gene symbol . |
---|---|---|---|---|---|---|---|---|
Down-regulated B leukemia probe sets | ||||||||
1422122_at | 0.21 | 0.06 | 0.43 | −6.57 | −6.89 | −6.36 | Fc receptor, IgE, low affinity II, α polypeptide | Fcer2a |
1451713_a_at | −0.05 | −0.09 | 0.18 | −6.26 | −5.85 | −5.85 | Fc receptor, IgE, low affinity II, α polypeptide | Fcer2a |
1438030_at | −0.28 | −0.01 | 0.06 | −5.23 | −4.94 | −4.27 | RAS, guanyl releasing protein 3 | Rasgrp3 |
1447998_at | 0.36 | 0.14 | 0.31 | −4.87 | −4.53 | −4.84 | Immunoglobulin heavy chain 4 (serum IgG1) | Igh-4 |
1427292_at | −0.31 | −0.37 | 0.00 | −4.47 | −2.90 | −3.62 | Immunoglobulin λ chain, variable 1 | Igl-V1 |
1439221_s_at | −0.18 | −0.15 | 0.00 | −4.44 | −4.21 | −4.85 | Tumor necrosis factor receptor superfamily, member 5 | Tnfrsf5 |
1443783_x_at | 0.01 | −0.01 | −0.16 | −4.17 | −4.56 | −4.67 | Histocompatibility 2, class II antigen A, α | H2-Aa |
1452521_a_at | −0.01 | −0.54 | −0.20 | −3.98 | −3.90 | −4.23 | Urokinase plasminogen activator receptor | Plaur |
1449473_s_at | −0.53 | −0.40 | −0.27 | −3.85 | −3.90 | −4.69 | Tumor necrosis factor receptor superfamily, member 5 | Tnfrsf5 |
1427306_at | 0.27 | −0.08 | 0.23 | −3.50 | −3.45 | −3.65 | Ryanodine receptor 1, skeletal muscle | Ryr1 |
1438031_at | −0.41 | −0.10 | −0.06 | −3.49 | −3.74 | −3.67 | RAS, guanyl releasing protein 3 | Rasgrp3 |
1442263_at | −0.15 | −0.27 | −0.25 | −3.48 | −3.56 | −3.09 | Regulator of G-protein signaling 13 | Rgs13 |
1419609_at | −0.32 | −0.15 | −0.34 | −3.45 | −3.90 | −3.75 | Chemokine (C-C motif) receptor 1 | Ccr1 |
1416055_at | −0.04 | −0.08 | 0.15 | −3.43 | −3.38 | −3.29 | Amylase 2, pancreatic | Amy2 |
1442544_at | −0.01 | −0.06 | 0.47 | −3.31 | −3.53 | −3.27 | Immunoglobulin heavy chain 4 (serum IgG1) | Igh-4 |
1451965_at | −0.56 | −0.42 | −0.44 | −3.22 | −3.69 | −3.67 | Immunoglobulin κ chain complex | Igk |
1425063_at | −0.07 | −0.29 | −0.02 | −3.15 | −2.98 | −2.85 | Fc receptor-like 1 | Fcrl1 |
1448861_at | 0.50 | −0.13 | 0.51 | −3.15 | −3.18 | −3.30 | Tnf receptor-associated factor 5 | Traf5 |
1425902_a_at | −0.16 | −0.41 | −0.48 | −2.84 | −2.54 | −2.90 | Nuclear factor of κ light polypeptide gene enhancer in B cells 2, p49/p100 | Nfkb2 |
1425289_a_at | −0.10 | 0.15 | 0.58 | −2.82 | −3.56 | −4.96 | Complement receptor 2 | Cr2 |
1420710_at | −0.05 | 0.37 | −0.40 | −2.70 | −2.12 | −2.23 | Reticuloendotheliosis oncogene | Rel |
1427576_at | −0.52 | −0.50 | −0.23 | −2.60 | −3.04 | −3.10 | Immunoglobulin κ chain, constant region | Igk-C |
1450912_at | −0.16 | −0.23 | 0.11 | −2.49 | −2.19 | −3.14 | Membrane-spanning 4-domains, subfamily A, member 1 | Ms4a1 |
1423226_at | −0.03 | 0.32 | 0.48 | −2.32 | −2.03 | −2.79 | Membrane-spanning 4-domains, subfamily A, member 1 | Ms4a1 |
1455019_x_at | −0.30 | −0.48 | 0.10 | −2.43 | −2.68 | −2.52 | Cytoskeleton-associated protein 4 | Ckap4 |
1421211_a_at | −0.38 | −0.14 | −0.41 | −2.37 | −3.83 | −3.85 | Class II transactivator | C2ta |
1420353_at | −0.36 | −0.57 | −0.53 | −2.36 | −3.66 | −3.51 | Lymphotoxin A | Lta |
1422828_at | −0.29 | −0.29 | −0.43 | −2.31 | −2.09 | −2.21 | CD3 antigen, δ polypeptide | Cd3d |
1415899_at | −0.54 | −0.24 | −0.57 | −2.15 | −2.50 | −3.38 | Jun-B oncogene | Junb |
1419714_at | 0.42 | −0.06 | 0.29 | −2.11 | −2.27 | −2.06 | Programmed cell death 1 ligand 1 | Pdcd1lg1 |
1447839_x_at | 0.56 | 0.55 | 0.08 | −2.08 | −2.23 | −2.22 | Adrenomedullin | Adm |
1425802_a_at | −0.26 | 0.23 | −0.06 | −2.07 | −2.25 | −4.45 | Fc receptor-like A | Fcrla |
Up-regulated B leukemia probe sets | ||||||||
1427276_at | 0.20 | 0.39 | 0.50 | 2.03 | 2.63 | 2.12 | SMC4 structural maintenance of chromosomes 4-like 1 (yeast) | Smc4l1 |
1452499_a_at | 0.48 | 0.09 | 0.16 | 2.03 | 2.17 | 2.34 | Kinesin family member 2A | Kif2a |
1436036_at | 0.40 | 0.10 | 0.08 | 2.08 | 2.53 | 2.79 | Wolf-Hirschhorn syndrome candidate 1 (human) | Whsc1 |
1439740_s_at | 0.20 | −0.01 | 0.14 | 2.09 | 2.62 | 2.16 | Uridine-cytidine kinase 2 | Uck2 |
1448531_at | 0.39 | 0.45 | 0.36 | 2.19 | 2.39 | 2.27 | Lamin B2 | Lmnb2 |
1417299_at | −0.24 | −0.31 | 0.23 | 2.38 | 2.94 | 2.50 | NIMA (never in mitosis gene a)-related expressed kinase 2 | Nek2 |
1420909_at | 0.20 | 0.21 | −0.01 | 2.40 | 3.59 | 3.57 | Vascular endothelial growth factor A | Vegfa |
1428853_at | 0.37 | −0.09 | −0.25 | 2.50 | 3.08 | 3.26 | Patched homolog 1 | Ptch1 |
1437716_x_at | −0.18 | −0.27 | −0.08 | 2.54 | 2.94 | 2.43 | Kinesin family member 22 | Kif22 |
1418969_at | 0.11 | −0.11 | −0.05 | 2.57 | 3.04 | 2.53 | S-phase kinase-associated protein 2 (p45) | Skp2 |
1415849_s_at | −0.30 | −0.53 | −0.46 | 2.61 | 3.02 | 2.97 | Stathmin 1 | Stmn1 |
1449293_a_at | −0.01 | −0.43 | −0.22 | 2.72 | 2.87 | 2.65 | S-phase kinase-associated protein 2 (p45) | Skp2 |
1423092_at | −0.27 | −0.57 | 0.49 | 2.74 | 3.13 | 3.10 | Inner centromere protein | Incenp |
1444031_at | 0.50 | 0.17 | 0.02 | 2.76 | 3.05 | 2.34 | Calcium/calmodulin-dependent protein kinase II, δ | Camk2d |
1417656_at | 0.29 | −0.06 | 0.51 | 2.77 | 2.90 | 2.52 | Myeloblastosis oncogene-like 2 | Mybl2 |
1417694_at | −0.20 | −0.39 | −0.19 | 2.81 | 2.83 | 4.08 | Growth factor receptor bound protein 2-associated protein 1 | Gab1 |
1439436_x_at | −0.01 | −0.44 | 0.18 | 2.83 | 3.38 | 3.08 | Inner centromere protein | Incenp |
1424128_x_at | −0.30 | −0.55 | 0.48 | 2.84 | 3.32 | 3.16 | Aurora kinase B | Aurkb |
1446669_at | 0.30 | 0.45 | 0.18 | 2.92 | 2.95 | 2.14 | Early B-cell factor 1 | Ebf1 |
1440244_at | 0.00 | 0.19 | 0.05 | 2.99 | 4.55 | 5.28 | Avian erythroblastosis virus E-26 (v-ets) oncogene related | Erg |
1424278_a_at | −0.54 | −0.46 | −0.47 | 3.09 | 3.58 | 3.10 | Baculoviral IAP repeat-containing 5 | Birc5 |
1460247_a_at | 0.09 | −0.12 | −0.29 | 3.21 | 3.47 | 3.31 | S-phase kinase-associated protein 2 (p45) | Skp2 |
1437580_s_at | −0.44 | −0.56 | −0.10 | 3.23 | 3.47 | 3.29 | NIMA (never in mitosis gene a)-related expressed kinase 2 | Nek2 |
1458447_at | 0.49 | 0.43 | 0.52 | 3.50 | 4.00 | 3.67 | Centromere protein F | Cenpf |
1415810_at | −0.19 | −0.39 | −0.35 | 3.50 | 3.56 | 3.55 | Ubiquitin-like, containing PHD and RING finger domains, 1 | Uhrf1 |
1419943_s_at | −0.50 | −0.52 | −0.03 | 3.50 | 4.23 | 3.84 | Cyclin B1 | Ccnb1 |
1416961_at | −0.11 | −0.12 | 0.34 | 3.56 | 4.14 | 3.69 | Budding uninhibited by benzimidazoles 1 homolog, β (Saccharomyces cerevisiae) | Bub1b |
1424991_s_at | −0.03 | −0.04 | 0.42 | 3.64 | 3.98 | 4.10 | Thymidylate synthase | Tyms |
1417938_at | −0.03 | −0.02 | 0.37 | 3.75 | 4.19 | 3.88 | RAD51-associated protein 1 | Rad51ap1 |
1448899_s_at | −0.38 | −0.31 | 0.24 | 3.76 | 4.13 | 3.84 | RAD51-associated protein 1 | Rad51ap1 |
1416155_at | 0.32 | 0.19 | 0.26 | 3.78 | 4.30 | 4.38 | High mobility group box 3 | Hmgb3 |
1415811_at | 0.37 | −0.03 | −0.11 | 3.91 | 3.95 | 3.94 | Ubiquitin-like, containing PHD and RING finger domains, 1 | Uhrf1 |
1418264_at | −0.04 | −0.39 | 0.35 | 4.16 | 4.52 | 4.55 | SoxLZ/Sox6 leucine zipper binding protein in testis | Solt |
1417910_at | −0.57 | −0.47 | −0.32 | 4.25 | 4.71 | 4.28 | Cyclin A2 | Ccna2 |
1434748_at | −0.27 | −0.36 | −0.21 | 4.30 | 4.78 | 4.21 | Cytoskeleton-associated protein 2 | Ckap2 |
1448205_at | −0.15 | −0.23 | 0.15 | 4.42 | 4.85 | 4.49 | Cyclin B1, related sequence 1 /// cyclin B1 | Ccnb1-rs1///Ccnb1 |
1416076_at | −0.53 | −0.45 | −0.19 | 4.47 | 5.18 | 4.81 | Cyclin B1 | Ccnb1 |
1452315_at | 0.05 | 0.27 | 0.57 | 4.48 | 4.82 | 4.58 | Kinesin family member 11 | Kif11 |
1439820_at | −0.08 | −0.09 | −0.13 | 4.48 | 4.48 | 3.95 | Early B-cell factor 1 | Ebf1 |
1424046_at | −0.04 | −0.02 | −0.03 | 4.56 | 5.27 | 4.79 | Budding uninhibited by benzimidazoles 1 homolog (Saccharomyces cerevisiae) | Bub1 |
1452314_at | −0.14 | −0.18 | 0.10 | 4.58 | 5.06 | 4.63 | Kinesin family member 11 | Kif11 |
1454694_a_at | −0.13 | −0.08 | 0.03 | 4.66 | 5.14 | 4.87 | Topoisomerase (DNA) II α | Top2a |
1418507_s_at | −0.26 | 0.01 | −0.06 | 4.88 | 5.92 | 4.41 | RIKEN cDNA D130043N08 gene | D130043N08Rik |
1447363_s_at | −0.23 | −0.28 | 0.10 | 4.97 | 5.50 | 5.14 | Budding uninhibited by benzimidazoles 1 homolog, β (Saccharomyces cerevisiae) | Bub1b |
1435306_a_at | −0.20 | −0.32 | 0.22 | 5.05 | 5.50 | 5.04 | Kinesin family member 11 | Kif11 |
1424967_x_at | −0.06 | 0.08 | 0.27 | 5.23 | 3.63 | 2.48 | Troponin T2, cardiac | Tnnt2 |
1418726_a_at | 0.29 | 0.11 | 0.20 | 5.49 | 4.30 | 3.17 | Troponin T2, cardiac | Tnnt2 |
1427161_at | 0.31 | 0.43 | 0.28 | 5.67 | 6.30 | 5.92 | Centromere autoantigen F | Cenpf |
1426817_at | 0.25 | 0.39 | 0.41 | 5.64 | 6.09 | 5.88 | Antigen identified by monoclonal antibody Ki 67 | Mki67 |
1420176_x_at | −0.27 | 0.14 | −0.04 | 7.08 | 7.05 | 7.00 | Immunoglobulin λ-like polypeptide 1 | Igll1 |
1448649_at | −0.02 | −0.24 | −0.17 | 9.58 | 9.56 | 9.18 | Glutamyl aminopeptidase | Enpep |
Down-regulated T leukemia probe sets | ||||||||
1427419_x_at | −2.15 | −8.36 | −8.79 | −0.26 | −0.06 | −0.26 | Chemokine (C-C motif) receptor 9 | Ccr9 |
1421919_a_at | −2.68 | −6.65 | −6.65 | 0.03 | −0.06 | −0.30 | Chemokine (C-C motif) receptor 9 | Ccr9 |
1425792_a_at | −2.79 | −3.33 | −5.75 | −0.18 | −0.26 | −0.30 | RAR-related orphan receptor gamma | Rorc |
1423954_at | −3.21 | −2.52 | −3.89 | 0.26 | 0.13 | −0.24 | Complement component 3 | C3 |
1447541_s_at | −2.12 | −2.46 | −2.49 | −0.53 | −0.33 | −0.30 | Integrin, α E, epithelial-associated | Itgae |
1450295_s_at | −2.23 | −2.13 | −2.88 | 0.11 | 0.36 | 0.13 | Poliovirus receptor /// DNA segment, Chr 7, ERATO Doi 458, expressed | Pvr /// D7Ertd458e |
1427411_s_at | −2.60 | −2.07 | −2.24 | −0.33 | −0.31 | 0.06 | Deleted in lymphocytic leukemia, 2 | Dleu2 |
1420413_at | −2.30 | −2.07 | −2.06 | 0.42 | 0.29 | 0.50 | Aolute carrier family 7 (cationic amino acid transporter, y+ system), member 11 | Slc7a11 |
Up-regulated T leukemia probe sets | ||||||||
1449835_at | 2.55 | 2.86 | 5.05 | −0.30 | −0.38 | −0.35 | Programmed cell death 1 | Pdcd1 |
Down-regulated B and T leukemia common probe sets | ||||||||
1427127_x_at | −6.03 | −4.87 | −2.83 | −5.10 | −5.83 | −5.70 | Heat shock protein 1B /// heat shock protein 1A | Hspa1b /// Hspa1a |
1452318_a_at | −5.74 | −4.92 | −3.09 | −4.73 | −5.26 | −5.81 | Heat shock protein 1B | Hspa1b |
1427126_at | −5.23 | −4.56 | −2.76 | −4.92 | −5.53 | −5.75 | Heat shock protein 1B | Hspa1b |
1448123_s_at | −3.86 | −3.54 | −3.37 | −2.85 | −2.70 | −2.36 | Transforming growth factor, β induced | Tgfbi |
1448162_at | −3.84 | −3.92 | −3.30 | −4.15 | −3.86 | −4.01 | Vascular cell adhesion molecule 1 | Vcam1 |
1456250_x_at | −3.57 | −3.18 | −3.79 | −2.29 | −2.18 | −2.24 | Transforming growth factor, β induced | Tgfbi |
1460423_x_at | −3.39 | −2.89 | −2.13 | −6.19 | −6.45 | −7.35 | Ig κ chain | IgM |
1418126_at | −2.89 | −2.92 | −2.91 | −2.02 | −2.34 | −2.80 | Chemokine (C-C motif) ligand 5 | Ccl5 |
1417756_a_at | −2.84 | −5.14 | −3.04 | −2.50 | −3.17 | −2.19 | Lymphocyte specific 1 | Lsp1 |
1449858_at | −2.83 | −2.82 | −2.50 | −4.78 | −4.68 | −2.89 | CD86 antigen | Cd86 |
1449164_at | −2.76 | −3.00 | −3.03 | −2.83 | −2.94 | −2.67 | CD68 antigen | Cd68 |
1418365_at | −2.71 | −3.02 | −2.34 | −4.61 | −4.43 | −5.66 | Cathepsin H | Ctsh |
1415989_at | −2.46 | −2.50 | −2.69 | −2.07 | −2.32 | −2.37 | Vascular cell adhesion molecule 1 | Vcam1 |
1434499_a_at | −2.44 | −2.70 | −6.15 | −2.72 | −2.91 | −2.62 | Lactate dehydrogenase 2, B chain | Ldh2 |
1448237_x_at | −2.43 | −2.82 | −5.89 | −2.01 | −2.07 | −2.07 | Lactate dehydrogenase 2, B chain | Ldh2 |
1450381_a_at | −2.23 | −3.10 | −2.91 | −2.74 | −3.38 | −3.19 | B-cell leukemia/lymphoma 6 | Bcl6 |
1450381_a_at | −2.23 | −3.10 | −2.91 | −2.74 | −3.38 | −3.19 | B-cell leukemia/lymphoma 6 | Bcl6 |
Up-regulated B and T leukemia common probe sets | ||||||||
1422967_a_at | 2.03 | 2.96 | 2.87 | 2.32 | 3.45 | 2.72 | Transferrin receptor | Tfrc |
1422198_a_at | 2.03 | 2.21 | 2.54 | 2.39 | 3.05 | 2.17 | Serine hydroxymethyl transferase 1 (soluble) | Shmt1 |
1425179_at | 2.15 | 2.31 | 2.71 | 2.80 | 3.32 | 2.52 | Serine hydroxymethyl transferase 1 (soluble) | Shmt1 |
1425923_at | 6.04 | 5.92 | 5.57 | 4.66 | 4.87 | 4.19 | v-myc myelocytomatosis viral-related oncogene, neuroblastoma derived (avian) | Mycn |